Edelfosine, apoptosis, MDR and Na+/H+ exchanger: induction mechanisms and treatment implications.
Harguindey
S
S
Department of Medical Oncology, Clinica La Esperanza, Vitoria, Spain. sharguindey@jet.es
Pedraz
J L
JL
Cañero
R G
RG
Katin
M
M
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017209:Apoptosis; D018432:Drug Resistance, Multiple; D010742:Phospholipid Ethers / Q000627:therapeutic use*; D017923:Sodium-Hydrogen Exchangers
D000970:Antineoplastic Agents; D010742:Phospholipid Ethers; D017923:Sodium-Hydrogen Exchangers; C026659:edelfosine